Effect of Cefoperazone/Sulbactam Combined with Levofloxacin on Healthcare Associated Pneumonia
Abstract
Objective To observe the clinical therapeutic effect and safety of cefoperazone/sulbactam combined with levofloxacin on healthcare-associated pneumonia(HCAP).Methods Seventy-six patients with HCAP were randomly divided into treatment group and control group.The treatment group(40 cases) was cured with levofloxacin and cefoperazone/sulbactam,while the control group(36 cases) with cefminox.The therapeutic effect and adverse reactions in both groups were observed and compared 5-10 days later.Results The total efficacy rates and bacterial clearance rates were 85.00% and 63.90% in treatment group,82.6% and 54.5% in control group,respectively.The differences between the two groups were statistically significant.Conclusion The combined therapy of cefoperazone/sulbactam and levofloxacin with a broad-spectrum and better antibacterial action has definite therapeutic effect and safety on health-care-associated pneumonia.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.